- Home
- TOI
TOI
The Oncology Institute Inc.
as 04-18-2025 1:44pm EST
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | CERRITOS |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.13 - $2.35 | Next Earning Date: | 05-13-2025 |
| Revenue: | $393,412,000 | Revenue Growth: | 21.33% |
| Revenue Growth (this year): | 23.95% | Revenue Growth (next year): | N/A |
Latest The Oncology Institute Inc. News
TOI Breaking Stock News: Dive into TOI Ticker-Specific Updates for Smart Investing
GlobeNewswire
19 days ago
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
Simply Wall St.
25 days ago
Oncology Institute Full Year 2024 Earnings: US$0.86 loss per share (vs US$0.92 loss in FY 2023)
GuruFocus.com
a month ago
Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q4 2024 Result
GlobeNewswire
a month ago
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
GlobeNewswire
a month ago
The Oncology Institute Announces $16.5 million Private Placement
GlobeNewswire
2 months ago
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
GlobeNewswire
2 months ago
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown
Simply Wall St.
2 months ago
Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying
Compare TOI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TOI The Oncology Institute Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.